Autologous Hematopoietic Stem-Cell Transplantation in Multiple Sclerosis: A Systematic Review and Meta-Analysis

INTRODUCTION: In 1995, the use of autologous hematopoietic stem-cell transplantation (AHSCT), which was previously used to treat hematological tumors, was introduced for severe autoimmune diseases such as multiple sclerosis (MS). AHSCT has proven its safety over the past few years due to technical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabizadeh, Fardin, Pirahesh, Kasra, Rafiei, Nazanin, Afrashteh, Fatemeh, Ahmadabad, Mona Asghari, Zabeti, Aram, Mirmosayyeb, Omid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333355/
https://www.ncbi.nlm.nih.gov/pubmed/35902484
http://dx.doi.org/10.1007/s40120-022-00389-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333355/
https://www.ncbi.nlm.nih.gov/pubmed/35902484
http://dx.doi.org/10.1007/s40120-022-00389-x

Ejemplares similares